Introduction
Endothelial cells are essential for coagulation and fibrinolysis processes. Their function disturbances lead to atherosclerosis [1] which is still the leading cause of death in the world.
Thrombomodulin (TM) is a marker of endothelial cells damage. TM is a transmembrane glycoprotein with antithrombotic properties. It inhibits thrombin which is the main factor of thrombus formation. Thrombin and thrombomodulin fusion on endothelial cells surface changes thrombin function from thrombotic to antithrombotic. It could be realized by protein C activation. The activated form (with protein S and phospholipid as cofactors) degrades Factor Va and Factor VIIIa and inactivates tissue factor plasminogen inhibitor [2, 3] .
Lovastatin is one of the statins representatives. The statins significantly reduce cholesterol level and significantly lower morbidity and mortality related to cardiovascular events [4, 5] . They improve endothelium function, inhibit macrophages and smooth muscles cells proliferation and migration [6] , influence hemostasis and inflammation processes, stabilize atherosclerotic plaques [7] [8] [9] [10] [11] [12] .
The influence of statins on genes related to hemostasis was investigated in relation to thrombomodulin, eNOS, E-selectin, PAI-1, VCAM-1, ICAM-1, endothelin [9, 10, [13] [14] [15] [16] [17] [18] [19] .
All investigators are unanimous that all kinds of the statins function are similar but differ in strength of influence [9] . The influence of lovastatin on hemostasis, especially on thrombomodulin was rarely presented. The aim of our in vitro study was an assessment of influence of increasing lovastatin concentrations on TM gene expression in endothelial cells. The experiment is a continuation of our earlier investigations [20] . . The reaction conditions were 50°C for 2 min and 95°C for 10 min, followed by 50 cycles of 95°C for 15 s and 60°C for 60 s for annealing and extention.
Results were assessed using ΔΔCt method which is a relative transcript quantification using Ct value of thrombomodulin gene (TM) comparing to reference gene GAPDH.
Lovastatin was received from Grodziskie Zak³ady Farmaceutyczne "Polfa" Sp. z o.o. from Grodzisk Mazowiecki, Poland. 
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Results
The increasing doses of lovastatin caused progressing TM gene expression rise. Fig. 1 shows the results of three experiments which are compared to controls values (culture without lovastatin) and showed as percentage. The lowest dose of lovastatin (0.1µmol/l) caused increase of TM gene expression of about 120% (not significant), higher doses (1.0 and 10.0 µmol/l) 400% and 600%, respectively (p<0.05). Differences between the lowest dose and higher doses ware statistically significant (p<0.05), however differences between doses 1.0 and 10.0 µmol/l were not significant.
Discussion
The statins are group of drugs of natural and synthetic origin. Most of studies did not show any significant differences in the function of individual statins, they show similar pharmacologic effect. The strength of effectiveness depends on the statins kind [9] . Our study was carried out using lovastatin of Polish pharmaceutical company POLFA Grodzisk. Most investigators used pitavastatin [9, 13, 15] and atorvastatin [13] [14] [15] 18] . Our in vitro study shows lovastatin influence on trombomodulin mRNA concentration in endothelial cells which was dependent on drugs dose (Fig. 1) . TM gene expression rose progressively from 116% to 613% comparing to controls as higher doses of lovastatin were added. Statistically significant differences were obtained between the lowest dose of statin (0.1 µmol/l) and higher doses (1.0 and 10.0 µmol/l), (p=0.0495). Threefold increase of TM gene expression after 24 hours incubation of endothelial cells with lovastatin (10.0µmol/l) comparing to control cells was reported by van Thienen [16] . The other statins also caused several or even more than ten times increase [9, [13] [14] [15] .
The induction of the increase of gene expression of TM which has the antithrombotic properties is an important function of lovastatin. Statins also cause a decrease of expression of prothrombotic factors such as: E-selectin, PAI-1, VCAM-1, ICAM-1, endothelin [13, 15, [17] [18] [19] and an increase of eNOS gene expression. Some investigators suggested that eNOS expression is strictly connected with TM expression [14, 16] . NO is an important endothelial factor which improves the function of endothelium by its antithrombotic and antiatherogenic action.
Wide spectrum of the functions of statins is difficult to explain only by their influence on lipid concentration. These drugs lower the cholesterol level by inhibiting the enzyme HMG-CoA reductase and have the influence on posttranslational proteins prenylation by Farnezyl-PP and Geranylgeranyl-PP which are products in cholesterol synthesis pathway. This mechanism is probably responsible for pleiotropic statins effect on different type of cells [21, 22] .
Our previous works showed an increased concentration of TM protein on endothelial cells surface after lovastatin exposition [20] . In the current study we showed also lovastatin dose-dependent increase of TM mRNA concentration which means an increased TM gene expression and an increased production of inhibitory protein. The increase of the expression of this thrombin receptor means higher potential inhibitory abilities of thrombomodulin as an effect of increasing lovastatin doses.
Summarizing, the explicit rise of TM gene expression as an effect of lovastatin action is a real proof of inhibitory function on blood hipercoagulability of this drug.
